Home
Live Updates
Chinas NMPA approves Zai Labs XACDURO NDA for pneumonia : comparemela.com
China's NMPA approves Zai Lab's XACDURO NDA for pneumonia
The NMPA's decision was based on the positive outcomes of the Phase III ATTACK trial.
Related Keywords
New Zealand ,
Australia ,
Vietnam ,
Republic Of ,
China ,
Japan ,
Chinese ,
Harald Reinhart ,
Drug Administration ,
Zai Lab ,
China National Medical Products Administration ,
Innoviva Specialty Therapeutics ,
National Medical Products Administration ,
Entasis Therapeutics ,
Greater China ,
Pharmaceutical Technology ,
comparemela.com © 2020. All Rights Reserved.